Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
287.16
+6.16 (2.19%)
Sep 30, 2026, 2:55 PM EDT - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $8.02 billion as of September 30, 2026. Its market cap has increased by 627.16% in one year.
Market Cap
8.02B
Enterprise Value
6.64B
1-Year Change
627.16%
Ranking
Category
Stock Price
$287.16
ChartMarket Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.02B, an increase of 1,048.60%. That is a compound annual growth rate of 50.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 8.02B | 8.78% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 9.29B |
| Arrowhead Pharmaceuticals | 9.27B |
| Protagonist Therapeutics | 9.24B |
| Cytokinetics | 9.22B |
| Caris Life Sciences | 8.93B |
| Vaxcyte | 8.43B |
| ABIVAX Société Anonyme | 8.28B |
| TG Therapeutics | 8.00B |